ASPM and pancreatic ductal adenocarcinoma: Recently, emerging evidence has illustrated that ASPM is expressed in malignant tissues and associated with the progression of several tumors, including lung carcinoma, gastric cancer, hepatocellular carcinoma, prostate cancer, and pancreatic ductal adenocarcinoma [10,11,13–16].